Phosphorus

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Phosphorus is a medication indicated in the treatment of hypophosphatemia.

Generic Name
Phosphorus
DrugBank Accession Number
DB14151
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 30.9738
Monoisotopic: 30.973761512
Chemical Formula
P
Synonyms
  • Phosphorous
  • Phosphorus, elemental

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to preventBone lossCombination Product in combination with: Cholecalciferol (DB00169), Calcium (DB01373)••• ••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Advanced B & T FormulaPhosphorus (100 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese cation (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Silicon (0.333 mg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg)CapsuleOralNutraceutical CorporationNot applicableNot applicableCanada flag
Anaplex TabPhosphorus (75.33 mg / tab) + Ascorbic acid (40 mg / tab) + Calcium (160 mg / tab) + Iodine (.05 mg / tab) + Magnesium oxide (50 mg / tab) + Nicotinamide (30 mg / tab) + Calcium pantothenate (15 mg / tab) + Potassium chloride (20 mg / tab) + Pyridoxine hydrochloride (40 mg / tab) + Vitamin A palmitate (2000 unit / tab) + Vitamin D (133.33 unit / tab)TabletOralAnabolic Laboratories Inc.1975-12-311996-10-02Canada flag
BiO-LiFE Premiton Soft CapsulePhosphorus (80 mg) + Ascorbic acid (60 mg) + Calcium (104 mg) + Cholecalciferol (400 IU) + Copper (1 mg) + Cyanocobalamin (6 mcg) + Folic acid (400 mcg) + Ginseng (100 mg) + Lipoic acid (25 mg) + Magnesium (5 mg) + Manganese cation (1 mg) + Nicotinamide (20 mg) + Calcium pantothenate (10 mg) + Potassium (4 mg) + Pyridoxine (2 mg) + Riboflavin (1.6 mg) + Rutin (20 mg) + Selenium (40 mcg) + Thiamine (1.5 mg) + Vitamin A (4000 IU) + Vitamin E (14.9 IU) + Zinc (1 mg)CapsuleOralBIO-LIFE MARKETING SDN. BHD.2020-09-08Not applicableMalaysia flag
BIOGROW MINPhosphorus (2 mg) + Boron (500 mcg) + Calcium (15 mg) + Chromium (16.8 mcg) + Copper (100 mcg) + Iodine (33.5 mcg) + Iron (3 mg) + Lithium carbonate (117 mcg) + Magnesium (5 mg) + Manganese cation (700 mcg) + Molybdenum (12.6 mcg) + Nickel cation (67 mcg) + Potassium (5 mg) + Selenium (16.7 mcg) + Silicon (12.5 mcg) + Vanadium (8.5 mcg) + Zinc (2 mg)Tablet, film coatedOralUNISON NUTRACEUTICALS SDN. BHD.2020-09-08Not applicableMalaysia flag
BIOGROW® VITEPhosphorus (2.5 mg) + Ascorbic acid (25 mg) + Beta carotene (500 IU) + Biotin (50 mcg) + Boron (50 mcg) + Bromelains (12.5 mg) + Calcium (2.25 mg) + Cholecalciferol (200 IU) + Choline (8.5 mg) + Chromium (10 mcg) + Copper (34 mcg) + Cyanocobalamin (2 mcg) + Folic acid (125 mcg) + Inositol (1.75 mg) + Iodine (56 mcg) + Iron (2 mg) + Magnesium (1.5 mg) + Manganese cation (750 mcg) + Molybdenum (9 mcg) + Nicotinamide (10 mg) + Pancrelipase amylase (12.5 mg) + Pantothenic acid (10 mg) + Papain (12.5 mg) + Potassium (2.5 mg) + Pyridoxine (5 mg) + Riboflavin (2 mg) + Selenium (17 mcg) + Silicon (9 mcg) + Thiamine (2 mg) + Thiamine (2.5 mg) + Vanadium (4 mcg) + Vitamin A (2500 IU) + Vitamin E (15 IU) + Zinc (2 mg)TabletOralUNISON NUTRACEUTICALS SDN. BHD.2020-09-08Not applicableMalaysia flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
27YLU75U4W
CAS number
7723-14-0
InChI Key
OAICVXFJPJFONN-UHFFFAOYSA-N
InChI
InChI=1S/P
IUPAC Name
phosphorus
SMILES
[P]

References

General References
  1. TITCK: Megadyn Pronatal (Multivitamin) Oral Tablet [Link]
Human Metabolome Database
HMDB0001315
ChemSpider
4575369
RxNav
8263
ChEBI
30207
Wikipedia
Phosphorus

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
4RecruitingTreatmentX-Linked Hypophosphatemia1somestatusstop reasonjust information to hide
3Unknown StatusTreatmentChronic Kidney Disease (CKD)1somestatusstop reasonjust information to hide
2, 3CompletedTreatmentOverweight / Pregnancy / Psychiatric Disorder NOS1somestatusstop reasonjust information to hide
1, 2CompletedTreatmentDent's Disease1somestatusstop reasonjust information to hide
Not AvailableCompletedNot AvailableChronic Kidney Disease (CKD)1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, film coatedOral
Tablet
Capsule
TabletOral
LiquidOral
CapsuleOral
Capsule, gelatin coatedOral
PowderOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0.3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity5.2 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-001i-9000000000-88317f9b56fea79262a0
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-b25ebf44fa1deb41a771
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-108.291565
predicted
DeepCCS 1.0 (2019)
[M+H]+110.04523
predicted
DeepCCS 1.0 (2019)
[M+Na]+116.777725
predicted
DeepCCS 1.0 (2019)

Drug created at June 28, 2018 19:42 / Updated at May 14, 2021 01:06